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suggesting an anoikis mechanism may contribute to apoptosisMonocytes may promote myofibroblast accumulation and apo-
in this model.ptosis in Alport renal fibrosis.
Background. In interstitial fibrosis, monocytes and myofi-
broblasts have been directly implicated in scarring, apoptosis,
and tissue necrosis. While much has been done to explore the
Most acute and progressive renal diseases culminaterole of these cell types individually in fibrosis, the interactive
in the common pathway of tubulointerstitial fibrosis. Thedependency of monocytes and myofibroblasts has been only
marginally explored. processes of interstitial scarring and cellular destruction
Methods. Alport mice were treated or not with a soluble associated with interstitial fibrosis share many character-
receptor inhibitor for transforming growth factor-1 (TGF-1), istics from one organ to another. There are two typeswhich was previously shown to inhibit the accumulation of
of cells that are thought to play key roles in this process,myofibroblasts, but not monocytes, in the tubulointerstitium.
Kidneys were examined for fibrosis using several matrix mark- monocytes and myofibroblasts.
ers, TGF-1 mRNA expression by in situ hybridization, apo- Myofibroblasts are often identified by expression of
ptosis using the terminal deoxynucleotidyl transferase-mediated -smooth muscle actin (-SMA) [1, 2], and have longuridine triphosphate nick end labeling (TUNEL) assay, expres-
been implicated as key players in the cellular pathologysion of matrix metalloproteinases (MMPs) and tissue inhibitors
underlying renal fibrosis [3]. They respond to transformingof metalloproteinases (TIMPS) by dual immunofluorescence
microscopy, MMP activity by gelatin and in situ zymography, growth factor-1 (TGF-1) by secreting matrix mole-
MMP mRNA expression by reverse transcription-polymerase cules associated with the evolution of interstitial scarring
chain reaction (RT-PCR), and basement membrane degrada-
[4, 5]. The number of myofibroblasts in renal biopsies hastion by dual immunofluorescence confocal microscopy and elec-
been proposed as a prognostic indicator for interstitialtron microscopy.
Results. Treated mice showed a markedly reduced accumu- fibrosis in patients with membranous nephropathy [6, 7].
lation of matrix proteins. Tissue monocytes express TGF-1 There is controversy over whether these cells arise in vivo
mRNA, and TGF-1 is required for myofibroblast accumula- via transmigration or transdifferentiation from proximaltion. The number of apoptotic cells was not influenced by
tubular epithelial cells or interstitial fibroblasts [8, 9].TGF-1 inhibition. Monocytes express MMP-2, MMP-9, TIMP-2,
and TIMP-3. MMP activity and mRNA expression is equally Aside from scarification, the functional role myofibro-
up regulated in treated and untreated Alport mice. Tubular blasts play in the process of renal fibrosis remains some-
basement membranes (TBM) around clusters of monocytes are what unclear.notably degraded. TGF-1 inhibition does not extend the life
Fibrosis is usually associated with a general inflamma-of Alport mice.
tory response. This can involve T cells, B cells, and mono-Conclusion. These studies demonstrate that monocytes may
influence myofibroblast accumulation via TGF-1, and that cytes, as is the case for autoimmune-nephritis models [10].
monocytes, and not myofibroblasts, are associated with tubular In some cases, only monocytes are observed. The role
atrophy in Alport mice. Elevated MMP expression and activity
of monocytes has often been associated with their abilityis associated with TBM destruction near monocytes clusters,
to secrete cytokines that promote the inflammatory pro-
cess and lead to cell death [11, 12]. Candidate cytokines
1See Editorial by Nikolic-Paterson, p. 1582.
mediating the apoptotic response include TGF-1 and
Key words: fibrosis, kidney, monocyte, Alport syndrome. tumor necrosis factor- (TNF-). In the unilateral ure-
teral obstructive (UUO) nephropathy model, inhibition
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shown to protect against renal failure in an acute model mTGFR:Fc for -smooth muscle actin (-SMA), which
system; however, these studies did not address apoptosis is an accepted marker for myofibroblasts, and compared
[18]. Monocytes have also been shown to secrete matrix them with untreated Alport mice. The myofibroblasts
metalloproteinases (MMPs), which has been functionally were virtually absent from these mice. The monocytes,
associated with transendothelial migration [19–24]. It however, were still present. Thus, treating Alport mice
has not been determined, however, whether monocyte- with the TGF-1 inhibitor allows the examination of
derived metalloproteinase activity plays a direct role in how monocytes influence tubulointerstitial pathology in
tubulointerstitial pathogenesis. Past studies addressing the absence of myofibroblasts. In this study, we exploit
the roles of monocytes and myofibroblasts in progressive this unique experimental system to show that monocytes
interstitial fibrosis address these cell populations individ- are primarily responsible for apoptosis associated with
ually. Studies aimed at how these cells interact and tubulointerstitial atrophy. Expression by monocytes of
whether there is a primary role of one cell population MMPs and their inhibitors associated with marked thin-
over another have not been adequately addressed. ning of tubular basement membranes suggests that an
The Alport mouse model was created by targeted mu- “anoikis” mechanism might contribute to monocyte-
tagenesis of the collagen 3 (IV) gene. The resulting mediated tissue destruction associated with tubulointer-
mouse model has all of the hallmarks of the human
stitial atrophy.disease [25, 26]. Earlier studies from our laboratory sug-
gested that TGF-1 plays a critical role in both glomeru-
lar and tubulointerstitial damage in the Alport mouse METHODS
model, and elevated TGF-1 mRNA was confirmed in Mice
human tissue from Alport patients [27]. These data were
All mice used in these studies were of the 129 Sv/Jfurther substantiated using a soluble receptor inhibitor
strain. The original Alport mouse was generated usingfor TGF-1 comprising the extracellular domain of the
the RW4 embryonic stem cell line (Genome Systems,murine TGF- type II receptor fused to the Fc region
St. Louis, MO, USA), which has a well-documented 129of murine immunoglobulin G (IgG2a) (abbreviated as
Sv/J origin. The chimeras were mated to 129 Sv/J micemTGFR:Fc). These studies, however, focused on the
purchased from Jackson Laboratories (Bar Harbor,role of TGF-1 in glomerular damage associated with
ME), and the resulting heterozygotes used to establishAlport syndrome [28].
the colony.In order to gain insight into the mechanism underlying
the role of TGF-1 in Alport interstitial disease, we
Drug treatmentsemployed a global analysis of gene expression using the
Affymetrix gene chip method [29]. Genes that were up- Treatment of mice with mTGFR:Fc (a chimeric solu-
or down-regulated were sorted using the classification ble receptor inhibitor of TGF-1 and TGF-3) was car-
scheme of Adams et al [30], and clustered within catego- ried out as described previously [28]. Injections were
ries using the GENE CLUSTER and TREEVIEW pro- twice weekly starting at 3 weeks of age (before observ-
grams (Berkeley, CA). Among the observations made, able fibrosis), and tissues were harvested when animals
it was noted that a number of transcripts known to be were 7 weeks of age. All experiments were performed
expressed by monocytes/macrophages were observed in in triplicate (three independent sets of animals, with
the Alport mouse. These included macrophage chemoat- three independent experiments on each set of animals),
tractive protein 1 (MCP-1), macrophage-inducible protein unless otherwise indicated.
(IP-10), macrophage-colony stimulating factor (M-CSF),
macrophage mannose receptor, and F4/80. All of these Gelatin zymography
transcripts were elevated between 6- and 24-fold in the Kidney samples from both the control and Alport mice
Alport mice relative to control littermates. were collected and placed immediately on dry ice, trans-
In this same study, the role of TGF-1 was explored
ferred to a freezer, and kept at –80C until use. Theby inhibiting the cytokine using mTGFR:Fc. As ex-
tissue was thawed, homogenized in Tris buffer (0.5 mol/Lpected, a number of TGF-1–responsive genes are down-
Tris-HCl, pH 7.5, containing 200 mmol/L NaCl and 0.2%regulated in kidneys from Alport mice treated with the
Triton X-100), and centrifuged at 10,000 rpm for 30 min-soluble receptor relative to untreated Alport mice. The
utes. The pellet was discarded, and the supernatant wasmacrophage-related transcripts, however, were relatively
aliquoted and stored at –80oC. The protein content inunaffected in kidneys of Alport mice treated with the
the supernatants was determined using the bicinchoninicsoluble receptor inhibitor for TGF-1. It is known that
acid (BCA) assay. Substrate gel electrophoresis (zymog-myofibroblasts are highly responsive to TGF-1 stimula-
raphy) was performed to identify whether the extractstion [31]. The cytokine induces many of the genes that
contained MMP activity and to identify the enzymesencode proteins involved in scarification, including type
involved. All samples were electrophoresed on a 9%I collagen, type IV collagen, fibronectin, and tenascin
[4, 5]. Thus, we examined kidneys from mice treated with sodium dodecyl sulfate-polyacrylamide gel electropho-
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resis (SDS-PAGE) containing gelatin (1.0 mg/mL) from Reverse-transcription-polymerase chain
reaction analysisswine skin (Sigma Chemical Co., St. Louis, MO, USA)
without prior heating or reduction. After electrophore- Total RNA was prepared using Trizol (Gibco/BRL,
sis, the gels were washed twice in 2.5% Triton-X 100 to Gaithersberg, MD, USA) as per the manufacturer’s in-
remove SDS, incubated in 50 mmol/L Tris-HCl buffer structions. Briefly, 5 g total RNA was reverse-tran-
(pH 7.5) containing 0.15 mol/L NaCl, 10 mmol/L CaCl2, scribed by using a first-strand cDNA synthesis kit using
SuperScript II (Gibco BRL). MMP-2 and MMP–9 mRNAand 0.02% (wt/vol) NaN3 with or without ethylenedi-
transcripts were analyzed semiquantitatively using spe-aminetetraacetic acid (EDTA) (10 mmol/L) for 16 hours
cific primers by reverse transcription-polymerase chainat 37C and stained with 0.1% Coomassie Brilliant Blue
reaction (RT-PCR). As an internal standard, expressionR250 (Sigma Chemical Co.). To ensure that gelatinolysis
of glyceraldehyde 3-phosphate dehydrogenase (GAPDH),was not due to either serine proteases or cathepsins,
a cellular housekeeping gene, was also analyzed. PCRpepstatin A (5mol/L) or phenylmethylsulfonyl fluoride
reactions were carried out in PTC 100 (M.J. Research,(PMSF) (1 mmol/L), in indicated experiments, were
Waltham, MA, USA) using AmpliTaq gold (Appliedadded to the incubation buffer. Gelatinolytic activity was
Biosystems, Branchburg, NJ, USA) with 1 cycle of 94Cvisualized by negative staining. Gelatinolytic activity of
for 10 minutes, 30 cycles of 94C for 60 seconds, 60Ceach gelatinase is evident as a clear band against the blue
for 60 seconds, 72C for 90 seconds followed by 72C forbackground of stained gelatin. Prestained SDS-PAGE
10 minutes, then held at 4C. Oligonucleotide primer
protein standards (Bio-Rad Laboratories, Richmond,
pairs were as follows: for GAPDH, 5-GGT GAA GGT
VA, USA) were used for estimating molecular weight. CGG AGT CAA CGG ATT TGG TCG-3 and 5-GGA
Varying amounts (based on micrograms of protein) of TCT CGC TCC TGG AAG ATG GTG ATG GG-3
tissue extracts were analyzed by gelatin zymography, (236 bp target size); for MMP-2, 5-CCT GAT GTC
and the results quantified based on histograms using CAG CAA GTA GAT GC-3 and 5-TTA AGG TGG
ImageQuant Software (Molecular Dynamics, Sunnyvale, TGC AGG TAT CTG G-3 (760 bp target size); for
CA, USA). The amounts loaded in each experiment fell MMP-9, 5-TTC TCT GGA CGT CAA ATG TGG-3
within the linear range. and 5-CAA AGA AGG AGC CCT AGT TCA AGG-3
(414 bp target size) based on the published sequences.
Detection of gelatinolytic activity by film Amplified products were separated on 2% agarose gel,
in situ zymography visualized by ultraviolet transillumination after staining
with ethidium bromide, and photographed. Semiquanti-The gelatinolytic activity was also detected by film
fication of MMP-2 and MMP-9 cDNAs was performedin situ zymography (FIZ) according to manufacturer’s
using densitometry, and comparison to GAPDH (inter-instructions (Fuji Photo Film Co., Ltd., Tokyo, Japan)
nal standard) from the same sample permitted gel-to-gelwith modifications. Briefly, fresh samples of kidney were
comparisons using an image analysis system (ImageQuantembedded without fixation in Tissue-Tek OTC aqueous
Software, Molecular Dynamics). All PCR experimentsembedding media (Sakura, Finetek, Torrance, CA).
included control reactions, which contained all compo-These frozen blocks were then sliced sequentially using
nents except cDNA. No band was ever detectable in thesecryostat microtome to prepare serial frozen-thin sections
control reactions. All PCR products were confirmed by(6 m thickness). These thin sections were placed on a
DNA sequencing. Data from three independent mousepolyethylene terephthalate base-film (Fuji Photo Film
sets were analyzed statistically using the Student t test
Co., Ltd.) coated with cross-linked gelatin of 7 m in
for both zymography and RT-PCR experiments. In-
thickness. The films with sections were incubated for 12 creases in MMP-2 and MMP-9 in Alport mice (either
hours at 37C in a humidified chamber and stained with treated or not with TGF-1 inhibitor) were found to be
1% Amido Black 10B in 70% methyl alcohol, 10% acetic significant relative to control littermates (P  0.005).
acid, and 10% glycerol for 10 minutes, destained in 70%
methyl alcohol, 10% acetic acid, and 10% glycerol for Northern analysis
10 minutes, and kept in 20% glycerol for 20 minutes. Total RNA was isolated from whole kidneys using
The sections were cover slipped, sealed, and imaged. Trizol (Gibco/BRL) according to the procedure de-
The gelatin in contact with the proteolytic areas of the scribed by the manufacturer. Trizol (20 g) was fraction-
sections was digested and, thus, negative staining indi- ated on formaldehyde gels, transferred by capillary blot
cated zones of enzymatic activity. To confirm the speci- to charged nylon, and probed with 32P-labeled cDNA
ficity of FIZ, frozen sections were also placed on gelatin- probe fragments. Probes were labeled to a specific activ-
coated films containing 1,10-phenanthroline, which is ity of about 5  108 counts per minute (cpm)/g DNA
using a random priming DNA labeling kit (Roche, India-known to inhibit the activity of MMPs.
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Fig. 1. Kinetics of myofibroblast and monocyte accumulation in the Alport mouse. (A ) Dual immunofluorescence immunostaining of tissue
sections from Alport renal cortex using antibodies against smooth muscle actin (SMA) (red) and laminin (green). (B ) Dual immunofluorescence
immunostaining of tissue sections from Alport renal cortex using antibodies against CD11b (red) and integrin 1 (green). The ages of the mice
are indicated. “Wild-type” mice are 8-week-old normal littermates. (C ) Colocalization of monocytes with CD11b immunostaining (in green) and
myofibroblasts with SMA immunostaining (in red) in Alport renal cortex at 5 weeks. Bar, 30 m.
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Fig. 2. The transforming growth factor- (TGF-) soluble receptor inhibits matrix accumulation in Alport tubulointerstitium (A to O ). Alport
mice were either injected with murine TGF- type II receptor fused to the Fc region of murine immunoglobulin (Ig)2a (mTGFR:Fc) [Alport
(Sol Rec)], or with vehicle (Alport) from 3 weeks to 7 weeks of age. Tissue sections were immunostained with antibodies specific for the indicated
matrix proteins. Bar, 60 m.
napolis, IN, USA). ULTRAhybtm (Ambion, Austin, then washed at high stringency [3 times for 30 minutes
in 1 standard sodium citrate (SSC), 0.5% SDS, at 65C]TX, USA) prehybridization and hybridization buffers
were used according to the manufacturer’s specifications. and exposed to x-ray film. The quality of the RNA prepa-
rations and the consistency of loading were assessed byFilters were prehybridized for at least 5 hours and then
hybridized overnight (14 hours) using 1 million dpm of staining gels with ethidium bromide and scanning the
18S and 28S ribosomal RNA bands using an Appliedprobe per mL of hybridization solution. The filters were
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The resulting fragment was cloned into the SacI site of
pBS SK (Stratagene, LaJolla, CA, USA) and sequence
verified. This plasmid (15g) was linearized using HindIII
to provide a 5 overhang. DNA was isolated using phe-
nol/chloroform extractions. DNA (1 g) was labeled as
recommended in the Boehringer Mannheim DIG Label-
ing Kit (Indianapolis, IN) using T7 polymerase. Spotting
the probe and labeled control onto nylon membrane and
developing as recommended in the nonradioactive in
situ hybridization application manual (Roche) estimated
the labeling yield. For hybridization, 6 m paraffin sec-
tions were digested in 3 g/mL proteinase K in 0.1 mol/L
Tris pH 7.5 for 10 minutes at 37C. They were prehybrid-
ized for 1 hour at 45C in 50% deionized formamide,
2  SSC, 10% Tween 20, and 1 mg Escherichia coli
tRNA. The hybridization solution consisted of 50 ng
heat-denatured ribroprobe, 50% deionized formamide,
8% dextran sulfate, 10% Tween-20, 2  SSC, 20%
tRNA, and 10 mg/mL boiled salmon sperm. Slides were
hybridized at 45C overnight. The DIG Wash and Block
Buffer Set (Boehringer Mannheim, Indianapolis, IN)
was used to develop the slides in conjunction with the
color substrate solution to which we added 25 mmol/L
levamisole. A short development time (approximately
10 seconds) was used to detect only cells expressing the
highest message levels.
Periodic acid-Schiff staining followed by terminal deoxy-Fig. 3. Transforming growth factor-1 (TGF-1) inhibition does not
nucleotidyl transferase-mediated uridine triphosphate nicksignificantly influence proteinuria in Alport mice. Urine was collected
from normal mice (control), Alport mice, and Alport mice treated with end labeling. Mice were heart-perfused with 2% para-
mTGFR:Fc (SR) at the indicated ages. (A) One microliter was resolved formaldehyde in phosphate-buffered saline (PBS). Peri-on a 15% polyacrylamide gel and stained with Coomassie blue. (B)
odic acid-Schiff (PAS) staining was performed by oxidiz-The three sets of animals were run in triplicate, the gels scanned by
optical densitometry, and quantified as arbitrary units (band intensity). ing 5 m paraffin sections in 0.5% periodic acid 10
minutes, staining with Schiff’s reagent 20 minutes, and
then dedifferentiating in 1% HCl in 70% ethanol and
with 1% ammonium hydroxide 5 seconds each. Sec-Imaging digital imaging system (Gel Imager 2000) and
tions were then pretreated by digesting tissue with 10software package. Appropriate ratios of ribosomal bands
g/mL proteinase K in 10 mmol/L Tris/HCl pH 7.5 forconfirmed that the RNA preparations were of high and
20 minutes at room temperature. Tissue was stained us-consistent quality. Quantitative densitometric scanning
ing the In Situ Cell Death Detection Kit (Roche) asconfirmed no more than a 10% variance in sample load-
recommended. BCIP/NBT (Sigma Chemical Co.) wasing. Quantitative differences in expression were assessed
used as a substrate solution. Slides were then cover-by phosphorimage analysis using a BioRad GS-525 phos-
slipped and imaged. Four different sets of animals werephorimager (Bio-Rad Laboratories) and subtracted for
used. The number of apoptotic cells in 20 fields (at 200background hybridization. The murine cDNAs for tissue
magnification) was counted. Interstitial cells and tubularinhibitors of metalloproteinase (TIMP-1 and TIMP-2) are
epithelial cells were scored separately. Sections weredescribed by Leco et al [32]. TIMP-1 was a 360 bp Pst1/
coded and counted blind. The data were analyzed usingKpn1 fragment. TIMP-2 was a 360 bp HindIII/EcoR1
Sigma Stat software (Chicago, IL, USA) and is presentedfragment. The probe for TIMP-3 was a 305 bp EcoR1/
as the mean 	 SEM.Pst1 fragment of the murine cDNA.
Immunodetection techniquesIn situ hybridization
All immunostains, with the exception of the terminalRiboprobe preparation. A 230 bp fragment of the
deoxynucleotidyl transferase-mediated uridine triphos-mouse TGF-1 cDNA was amplified from reverse tran-
phate nick end labeling (TUNEL) stains, were carriedscribed 13-day-old mouse embryonic RNA using the fol-
out on fresh-frozen 4 m sections of kidney tissue. Priorlowing primers: forward, 5-TCGCATCCCAGGACCC
TC-3, reverse, 5-GGTCTCCCAAGGAAAGGTAG-3. to OCT embedding, the tissue was soaked for 30 minutes
Rodgers et al: Monocytes and tubular epithelial cell death1344
Fig. 4. Transforming growth factor-1 (TGF-1) protein and mRNA is expressed by monocytes mTGFR:Fc-treated Alport mice. Dual immuno-
fluorescence analysis of control (A, B, and C ) and Alport (D, E, and F ) mice tissue sections from 7-week-old control and mTGFR:Fc-treated
Alport mice were reacted with antibodies specific for TGF-1 (A and D) or monocytes (anti-CD11b) (B and E). Merged images illustrate TGF-1
protein colocalizes with monocytes in Alport interstitium (F). Paraffin-embedded sections from control (G) and mTGFR:Fc-treated Alport (H)
mice were hybridized to an antisense riboprobe specific for TGF-1. Interstitial cells positive for TGF-1 mRNA are likely monocytes. Bar, 40 m.

at 5C in 15% sucrose and then 30% sucrose in 1  PBS. antimouse SMA (Sigma Chemical Co.) 1:100; FITC-con-
jugated rat-antimouse monoclonal against CD-2 pur-The tissue sections were collected on Superfrost/Plus
microscope slides (Fisher Scientific, Pittsburgh, PA, USA), chased from Southern Biotechnology (Birmingham, AL,
USA) and used at 1:100; FITC-conjugated rat antimousethen fixed using 100% ice-cold acetone for 10 minutes
and air-dried for a minimum of 3 hours at room tempera- monoclonals against CD-4 and CD-8 purchased from
BD Pharmingen (San Diego, CA, USA) and used atture. Primary antibodies were diluted in 7% nonfat dry
milk made in 1  PBS and allowed to react for 3 hours 1:100; rabbit antihuman TGF-1 was purchased from
Promega (Madison, WI, USA) and used at 1:150. Allat room temperature. The tissue was washed, and fluo-
rescein-conjugated secondary antibodies were allowed secondary antibodies were purchased from Chemicon
and used at a dilution of 1:100 in 7% nonfat dry milkto react for 2 hours at room temperature. The sections
were washed again and coverslipped using Vectashield made in 1  PBS. Immunoperoxidase immunostaining
mounting medium (Vector, Burlingame, CA, USA). was performed as described previously. [27] Anti-colla-
Both the CD11b and -SMA antibodies were directly gen I was purchased from Biogenesis (Sandown, NH),
conjugated to a fluorescent marker [Cy3 for -SMA and and used at 1:100. Antivimentin antibodies were pur-
either phycoerythin (PE) or fluorescein isothiocyanate chased from Chemicon and used at 1:50. All experiments
(FITC) for CD11b]. These antibodies were allowed to were performed on at least three independent sets of
react for 2 hours at room temperature. When used in animals, and fields chosen were representative. Results
conjunction with another antibody, either CD11b or between animal sets were not noticeably different. For
-SMA was added at the same time as the secondary all histology, except confocal imaging, images were cap-
antibody. When CD11b and -SMA were used together, tured using an Olympus BH-2 immunofluorescence mi-
the entire reaction was completed in 2 hours. For confo- croscope (Olympus, Tokyo, Japan) fitted with a SpotRT
cal images, 30 m frozen sections were used. Antilam- digital camera and Image Pro-Plus image analysis soft-
inin-1 antibody was allowed to react for 20 hours at room ware. Final figures were assembled using Adobe Pho-
temperature. Following three 15-minute washes with 1 toshop software.
PBS, Alexa secondary antibody (Molecular Probes, Eu- Proteinuria measurements. Urine was collected by
gene, OR, USA) was added in conjunction with FITC- placing the animal in a clean cage and inspecting periodi-
conjugated anti-CD11b and allowed to react for 4 hours cally (every 5 minutes). One microliter was fractionated
at room temperature. The tissue was washed again and on a 15% polyacrylamide gel, and stained with Coomas-
imaged on a confocal laser microscope (Radiance 2000; sie blue. Triplicate samples from three sets of mice were
Bio-Rad) attached to a Nikon E800. The antibodies used analyzed, the gels scanned, and the results quantified
and their dilutions were as follows: rabbit antihuman based on histograms using ImageQuant Software (Mo-
MMP-2 (Chemicon, Temecula, CA, USA) 1:100; rabbit lecular Dynamics).
antihuman MMP-9 (Chemicon) 1:100; rabbit antihuman
TIMP-1 (gift from W. Stettler-Stevenson, NIH) 1:1500;
RESULTSrabbit antihuman TIMP-2 (gift from W. Stettler-Steven-
son, NIH) 1:100; rabbit antihuman TIMP-3 (Sigma Chemi- The relative kinetics of monocyte and myofibroblast
accumulation as a function of Alport tubulointerstitialcal Co.) 1:100; monoclonal antimouse CD11b (Phar-
mingen, San Diego, CA, USA) 1:15; monoclonal disease progression was determined using dual immuno-

Fig. 13. Tubular basement membrane architecture is disrupted in Alport mice in regions near pockets of monocytes. Dual immunofluorescence
confocal microscopy was employed using antibodies specific for basement membranes with antilaminin-1 immunostaining (in green), monocytes
with anti-CD11b (in red), or both. (A, B, and C ) Punctate immunostaining (A, arrows) indicative of basement membranes undergoing active
degradation, and invasion of the lumen of the tubules by monocytes (C, asterisk). Ultrastructural analysis of tubular basement membranes by
transmission electron microscopy showed basement membranes in control mice (D) were relatively thick compared to either untreated (E) or
murine TGF- type II receptor fused to the Fc region of murine immunoglobulin (Ig)2a (mTGFR:Fc)-treated (F) Alport mice (arrows indicate
tubular basement membrane staining). Tubular basement membranes in regions outside pockets of monocytes were not thinned (data not shown).
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fluorescence microscopy. Figure 1A illustrates anti-SMA ing antibodies specific for TGF-1 (in green), and mono-
cytes (anti-CD11b, in red). Figure 4 B and C showsimmunostaining (in red), which marks myofibroblasts,
on a background of antilaminin-1 immunostaining (in immunostaining for TGF-1 around tubules of normal
mice. While the tubular immunostaining is also observedgreen), which is used to illustrate the tissue architecture.
Myofibroblasts are first observed at about 4 weeks of age, in Alport mice (Fig. 4 E and F), significant interstitial
immunostaining is also observed around monocytesand progressively accumulate, initially in the interstitial
space, around the glomeruli. Between 6 and 8 weeks of (compare Fig. 4 D and E). Interestingly, resident mono-
cytes do not express TGF-1 (Fig. 4 B and C, arrows).age, myofibroblasts accumulate throughout the intersti-
tial space. Animals die from end-stage renal failure be- Kidneys from these same mice were further examined by
in situ hybridization using a probe specific for TGF-1.tween 8 and 9 weeks of age. Figure 1B illustrates the
kinetics of accumulation of monocytes immunostained Development of the chromagenic substrate was limited
so only the cells expressing the highest levels of TGF-1with anti-CD11b antibodies (in red) on a background of
anti-integrin 1 immunostaining (in green). The mono- mRNA would be visible. Previous studies from our labo-
ratory [27] and others [35] show that glomerular andcytes appear at about the same time as the myofibro-
blasts, between 3 and 4 weeks of age. Like the myofibro- tubular cells synthesize TGF-1 mRNA. Figure 4H
shows that interstitial cells, which are likely monocytesblasts, monocytes are first observed in the interstitium
surrounding the glomeruli, and progressively spread to (since myofibroblasts are not present), express TGF-1
mRNA. Combined, the in situ hybridization and immu-localize throughout the interstitial space. Figure 1C shows
that monocytes and myofibroblasts colocalize (SMA in nostaining data implicate monocytes as a source (but not
the only source) of TGF-1.red and CD11b in green) in the interstitial space sur-
rounding the glomeruli in 5-week-old Alport mice. In many renal diseases, a host of different immune
cell types make their way into the interstitial space. ToIn a related publication we showed that Alport mice
treated with a soluble receptor-inhibitor for TGF-1 determine whether other immune cells are present in
the Alport tubulointerstitium, tissue sections were sub-failed to accumulate myofibroblasts, but did show sub-
stantial accumulation of monocytes [29]. Thus, we con- jected to immunostaining using antibodies specific for B
cells (anti-CD2), T-helper cells (anti-CD4), and cytolyticcluded that the mechanism driving the accumulation of
myofibroblasts must be TGF-1 dependent. Further ex- T cells (anti-CD8). Figure 5 A to C show no significant
accumulation of any of these immune cells in the intersti-tending these studies, Alport mice were either treated
or not with mTGFR:Fc from 3 weeks to 7 weeks of age. tium of 7-week-old Alport mice. Thus, monocytes are
the primary population of immune cells present in theThe kidneys were examined immunohistochemically for
scarification using antibodies specific for several matrix Alport tubulointerstitium at later stages of fibrosis.
It was previously reported that Alport mice treatedproteins known to accumulate as a function of progres-
sive fibrosis. Figure 2 shows that accumulation of type with mTGFR:Fc do not live any longer than untreated
Alport mice [28]. To determine whether tubular epithe-IV collagen 1 and 2 chains, laminin-1, fibronectin,
and type I collagen are markedly attenuated in TGF- lial cell apoptosis might contribute to tubular atrophy in
these mice, TUNEL immunostaining was performed on1–treated versus untreated Alport mice, presumably
owing to the absence of myofibroblasts, which are thought kidney sections from 7-week-old Alport mice and Alport
mice treated with mTGFR:Fc. Slides were counter-to be the primary cellular source of matrix deposition in
fibrosis [33, 34]. The relative absence of vimentin immuno- stained using PAS to allow differentiation of apoptotic
tubular epithelial cells from apoptotic interstitial cells,staining in mTGFR:Fc–treated Alport mice further sup-
ports the suppressed accumulation of interstitial fibro- and the two populations scored independently. Four in-
dependent sets of control and Alport mice were used,blasts compared to untreated Alport mice (Fig. 2 M to O).
Treatment of mice with the TGF-1 inhibitor had no and the number of apoptotic cells counted in 20 fields
at 200 magnification. Figure 6 shows representativesignificant influence on the progression of proteinuria
(Fig. 3), suggesting that effects of TGF-1 inhibition fields from normal (Fig. 6, top left panel), Alport (Fig.
6, top middle panel), and mTGFR:Fc-treated Alporton glomerular filtration were not indirectly influencing
observed changes in the interstitium. mice (Fig. 6, top right panel). Quantitative analysis of
apoptotic cells in treated and untreated Alport kidneysSince monocytes and myofibroblasts colocalize (Fig.
1C), and inhibition of TGF-1 inhibits accumulation of revealed no significant difference between the two
groups (Fig. 6, bottom panel). A great majority (
90%)myofibroblasts [29], it is possible that monocytes induce
accumulation of myofibroblasts in the interstitium via of the apoptotic cells were tubular epithelial cells. In
some fields, most or all of the epithelial cells in an individ-secretion of TGF-1. To determine whether the intersti-
tial monocytes express TGF-1, kidney sections from ual tubule were apoptotic. Thus, neither TGF-1 nor myo-
fibroblasts significantly influence tubular epithelial cellmice treated with mTGFR:Fc (lacking myofibroblasts)
were examined by dual immunofluorescence analysis us- apoptosis in the Alport mouse.
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Fig. 5. B cells and T cells are virtually absent in the renal cortex of Alport mice. Cryosections from a 7-week-old Alport kidney (A, B, and C )
and spleen (D, E, and F, used as a positive control) were examined by immunohistochemical staining using antibodies specific for B cells (anti-
CD2), T-helper cells (anti-CD4), and cytolytic T cells (anti-CD8). Note the relative absence of immunostaining in Alport kidneys relative to spleen.
Bar, 30 m.
The massive tissue damage in the Alport tubulointer- analysis) in the Alport kidneys relative to controls. These
experiments were repeated for three different sets ofstitium may be due to activities of the monocyte cell
population. Monocytes are known to express MMPs, animals, and the results did not vary by more than 20%.
Immunofluorescence analysis using antibodies specificwhich might contribute to the pathology [20]. To exam-
ine the relative activity of MMPs in normal versus Alport for MMP-2, MMP-9, and TIMP-1, TIMP-2, and TIMP-3
in 7-week-old normal versus Alport mice is shown inmice, protein extracts from renal cortex of normal and
Alport mice were analyzed by gelatin zymography. Fig- Figure 9. MMP-2 and MMP-9 immunostaining is consis-
tent with gelatin zymography, in that both metallopro-ure 7 shows a small increase in MMP-2 activity, and a
sharp increase in MMP-9 activity in extracts from Alport teinases are elevated in Alport mice relative to controls.
Expression of MMP-2 in normal animals appears to bekidneys relative to controls. The activity is abolished by
EDTA, but not by PMSF or pepstatin A, verifying that weak and confined to the tubules, while in Alport mice
strong immunostaining is observed in accumulated inter-it is metalloproteinase activity, and not due to serine
proteases or cathepsins. stitial cells. MMP-9 immunostaining is confined to the
mesangial matrix of glomeruli and appears to accumulateMetalloproteinase activity is regulated, in part, by the
TIMP (tissue inhibitor of metalloproteinase) family of pro- in the tubular basement membranes and interstitium of
normal mice. While the localization is the same in Alportteins [36, 37]. Northern blot analysis was performed to
examine mRNA levels for TIMP-1, TIMP-2, and TIMP-3 mice, significantly more immunostaining is apparent in
the interstitial spaces. With regard to TIMP localization,in normal versus Alport kidney from 7-week-old animals.
Figure 8 shows that the mRNA levels for TIMP-1 are these data illustrate that while more TIMP-1 protein is
present in Alport mice versus controls, levels do notmarkedly up-regulated in the Alport mouse (
50-fold
by phosphorimage analysis of the blot). This is consistent reflect the marked differences observed at the level of
mRNA. Similarly, TIMP-3 is elevated in Alport renalwith reports for both obstructive nephropathy and pro-
tein-overload proteinuria [38, 39]. TIMP-2 is also up-regu- cortex relative to that in control tissue, in contrast with
observed changes at the mRNA level (Fig. 8). Combined,lated in Alport kidneys relative to controls; however, the
induction (fourfold by phosphorimage analysis) is not as the data in Figures 8 and 9 suggest that expression of
TIMP-1 and TIMP-3 proteins in the Alport kidneys maygreat as that for TIMP-1. Interestingly, mRNA for
TIMP-3 is down-regulated (2.5-fold by phosphorimage be controlled largely at the posttranscriptional level.
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Fig. 6. Transforming growth factor-1 (TGF-1) inhibition does not influence apoptosis or tubular atrophy associated with Alport interstitial
disease. (Top panel) Tissue sections from control (C), Alport (A), and Alport mice treated with murine TGF- type II receptor fused to the Fc
region of murine immunoglobulin (Ig)2a (mTGFR:Fc) (SR) from 3 to 7 weeks of age were screened for apoptotic cells using the terminal
deoxynucleotidyl transferase-mediated uridine triphosphate nick end labeling (TUNEL) immunostaining method, then counterstained using by
periodic-acid Shiff (PAS). Apoptotic cells in the interstitial space (I) and the tubulointerstitium (T) were counted in 20 fields for four independent
experiments. (Bottom panel) The bars represent the mean and standard deviation per field for four independent sets of mice. Bar, 30 m.
To assess whether observed changes in MMP and These data suggest that monocytes are the primary
source of elevated MMP-2 and MMP-9 activity in theTIMP mRNA expression might be attributable, in part,
to increased numbers of monocytes in the Alport kid- Alport kidneys. If true, then Alport mice treated with
mTGFR:Fc, which have interstitial monocytes, but areneys, dual immunofluorescence analysis was performed
using antibodies specific for the MMPs and TIMPs in virtually devoid of myofibroblasts, should have elevated
levels of MMP activity and mRNA similar to that incombination with the CD11b marker for monocytes. The
results in Figure 10 illustrate that monocytes are indeed untreated Alport mice. To test this, both gelatin zymog-
raphy and RT-PCR were performed using kidneys frommaking MMP-2 and MMP-9, as well as TIMP-2 and
TIMP-3, as these proteins colocalize with the CD11b 7-week-old normal mice compared with Alport mice ei-
ther treated or not with mTGFR:Fc. Kidneys from themarker for monocytes. The CD11b marker did not colo-
calize with TIMP-1, suggesting that monocytes do not treated mice were immunostained using SMA-specific
antibodies and determined to be devoid of myofibroblastssynthesize appreciable amounts of this protein.
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Fig. 7. Interstitial disease in the Alport mouse
is associated with elevated matrix metallopro-
teinase (MMP-2 and MMP-9) activity. Gelatin
zymography of normal and Alport renal cor-
tex from 7-week-old mice illustrates elevated
MMP-2 and MMP-9 gelatinase activity. The
gelatinase activity is inhibited by ethylenedi-
aminetetraacetic acid (EDTA), but not by
pepstatin A or phenylmethylsulfonyl fluoride
(PMSF), verifying that is indeed MMP-2 and
MMP-9.
mRNA (Fig. 11 C and D) compared to either treated or
untreated controls. MMP-2 levels were slightly elevated
and, like MMP-9, MMP-2 induction was not abrogated
by mTGFR:Fc.
Since both the levels of MMPs and TIMPs are modu-
lated in Alport kidneys, the actual amount of active
MMP in the tissue is not evident by the experiments
presented thus far. To address this, FIZ was performed.
Frozen tissue sections were collected onto gelatin-coated
slides, and then incubated in a humidified chamber. Un-
der these conditions, the endogenous MMP activity can
be visualized in the context of the tissue architecture.
Unlike the gelatin zymograms shown in Figure 11A, in
which the pro-form of MMP-2 and MMP-9 have gela-
tinolytic activity, this system detects only the active form
of metalloproteinase [40]. The results in Figure 12 illus-
trate that very little gelatinolytic activity is observed in
control mice, while both Alport mice and Alport mice
treated with mTGFR:Fc show significant activity which
appears to localize to interstitial locations in the cortex
(see inset, bottom panel), consistent with monocyte lo-
calization.
Elevated MMP activity in tubulointerstitial monocytes
could potentially damage tubular basement membranes.
Fig. 8. Northern blot analysis of tissue inhibitors of metalloproteinase To address this possibility, basement membranes sur-
(TIMP) mRNAs from 7-week-old normal and Alport mice. Northern
rounding the tubular epithelial cells near clusters ofblots were probed with labeled cDNAs corresponding to the indicated
TIMPs. An additional blot was probed with the cDNA encoding glycer- monocytes were examined in Alport mice and Alport
aldehydes-3-phosphate dehydrogenase (GAPDH), which is constitu- mice treated with mTGFR:Fc . Both dual immunofluo-tively expressed, as a control for RNA loading on the gels. C, normal
rescence confocal microscopy and transmission electronkidney RNA; A, Alport kidney RNA.
microscopy were used to examine tubular basement
membrane destruction in 7-week-old Alport mice rela-
tive to controls. The results in Figure 13 illustrate that(data not shown). The results in Figure 11 show that
immunostaining of the tubular basement membranes istreatment of normal mice with mTGFR:Fc has no effect
degraded near clusters of monocytes as evidenced byon MMP activity. Both Alport mice and Alport mice
punctate immunostaining of basement membranes neartreated with mTGFR:Fc had similarly elevated levels
of both MMP-9 activity (Fig. 11 A and B) and MMP-9 the monocyte cluster (Fig. 13 A to C). Monocyte invasion
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Fig. 9. Alport mice show elevated matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinase (TIMP) protein in the tubulointersti-
tium. Kidney sections from 7-week-old normal and Alport mice were immunostained using antibodies specific for the indicated MMP or TIMP
proteins. Bar, 40 m.
of the tubular lumen is also evident (Fig. 13C, asterisk). (Fig. 13D). Combined, these data strongly suggest active
degradation of tubular basement membranes in regionsThis active basement membrane destruction was ob-
of high monocyte density.served around all monocyte clusters examined. Trans-
mission electron microscopy reveals basement mem-
DISCUSSIONbranes within monocyte clusters are markedly thin to
absent in both Alport mice (Fig. 13E) and Alport mice The cellular mechanism of progressive fibrosis has
been regarded as a coordinated effect of cellular destruc-treated with mTGFR:Fc (Fig. 13F) relative to controls
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Fig. 10. Monocytes express matrix metalloproteinase (MMP-2, MMP-9) and matrix metalloproteinase (TIMP-2 and TIMP-3) (A to O ). Dual
immunofluorescence staining was performed kidneys from 7-week-old Alport mice using antibodies specific for the indicated MMPs or TIMPs (in
green) and CD11b monocyte marker (in red). Merged images (Both) illustrate that the tissue monocytes are making MMP-2, MMP-9, TIMP-2,
and TIMP-3, but not TIMP-1. Bar, 60 m.
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Fig. 11. Elevated gelatinase activity in Alport kidneys is not due to transforming growth factor-1 (TGF-1). Renal cortex from kidneys of normal
(lanes 1 and 2) and Alport (lanes 3 and 4) mice that were injected from 3 to 7 weeks with either murine TGF- type II receptor fused to the Fc
region of murine immunoglobulin (Ig)2a (mTGFR:Fc) (lanes 2 and 4) or with vehicle (lanes 1 and 3) were analyzed for matrix metalloproteinase
(MMP) activity and mRNA expression. (A and C) Gelatin zymograms were scanned to produce histograms. (B ) Histograms illustrate that TGF-1
inhibition does not influence the increase in MMP-2 and MMP-9 enzyme activities in Alport kidneys. (D ) Similarly, reverse transcription-polymerase
chain reaction (RT-PCR) of RNAs from these same kidney were scanned to produce histograms that illustrate TGF-1 is not involved in the
elevated mRNA levels for the MMPs in Alport kidneys. Standard deviations were derived from three independent animal sets (P 
 .005). C,
control; C(SR), normal mouse treated with mTGFR:Fc; A, Alport; A(SR), Alport mouse treated with mTGFR:Fc; GAPDH, glyceraldehydes-
3-phosphate dehydrogenase.
tion and scarification, which are mediated by inflamma- noted, however, that monocytes are not the only source
of TGF-1. Thus, the data presented suggest, but dotory cells and myofibroblasts. In this study, we show
that inhibition of TGF-1 blocks the accumulation of not prove, that monocyte secretion of TGF-1 promotes
accumulation of myofibroblasts. We show that MMPmyofibroblasts, but not monocytes, in the tubulointersti-
tium of Alport mice. Under the conditions of TGF-1 activity is elevated in Alport kidneys relative to controls.
Elevated levels of MMP are not sensitive to TGF-1inhibition, scarification is inhibited; however, cellular
apoptosis and tubular atrophy continue to progress. We inhibition. The monocytes in Alport mice express high
levels of MMP-2 and MMP-9, and likely are primarilyshow that monocytes and myofibroblasts colocalize in
the early stages of progressive fibrosis and that mono- responsible for the observed induction of both MMP-2
and MMP-9 mRNA and enzyme activity. For MMP-9,cytes express TGF-1. These data suggest a potential
interaction where monocytes stimulate the accumulation the tubules also appear to contribute to elevated enzyme
levels (Fig. 9). Tubular basement membranes withinof myofibroblasts via secretion of TGF-1. It should be
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pockets of monocytes show severe ultrastructural dam-
age, suggesting an “anoikis” mechanism might contrib-
ute to the cellular damage associated with tubulointersti-
tial atrophy in the Alport mouse. It should be noted,
however, that other mechanisms such as localized isch-
emia or cytotoxic cytokines might be contribute to or
be responsible for the observed tissue atrophy.
A mechanistic link between monocytes and myofibro-
blasts has been alluded to in earlier work. Danilewicz,
Antoszczyk, and Wagrowska-Danilewicz [41] showed a
correlation between myofibroblasts and CD68-positive
cells in mesangiocapillary glomerulonephritis, suggesting
a causative link between monocytes and myofibroblasts.
Blockade of the angiotensin II receptor inhibits myofibro-
blasts accumulation, but does not affect monocyte accumu-
lation, possibly through inhibition of TGF-1 [42].
Prior to the studies described herein, there has been
little work done on the association of MMP expression
by tissue monocytes and progressive tubular atrophy.
Expression of MMP-9 by macrophages has been impli-
cated in glomerular sclerosis [43]. It is well known that
activated peripheral blood monocytes produce MMPs
[19–23]. It is equally well known that epithelial cells
deprived of contact with basement membranes will un-
dergo apoptosis, a response referred to as “anoikis”
[44, 45]. We show that the tissue monocytes accumulating
in the Alport model express MMPs, that the MMPs are
in the active form, and that the basement membranes near
clusters of monocytes are invariably thinned and sometimes
absent. We show that TIMP-2, which is required for
activation of pro-MMP-2 [36, 46], is also expressed by
tissue monocytes, which might contribute to tubular
basement membrane destruction. Thus, it is likely that
at least some of the apoptotic cells observed might be
dying through “anoikis.” The “anoikis” mechanism can be
mediated by integrins [47], in particular, 51 and v3 [48].
The latter is expressed in the distal tubules of the kidney
[49]. The existence of “death receptors” has also been
postulated; however, such receptors, which are obligatorily
linked to the intracellular cascade of caspase activation,
remain elusive [50]. It is likely that other integrin-mediated
signaling events might be found to trigger “anoikis” as
studies in this relatively new area progress.
An alternative, and more popular explanation for the
loss of tubular epithelial cells, is cytokine cytotoxicity.
It has been demonstrated that elevated expression of
Fig. 12. In situ zymography reveals active matrix metalloproteinase TNF- is associated with tubular epithelial cell apoptosis
(MMP) in Alport renal cortex. Cryosections of kidneys from 7-week- in vivo [51, 52]. Antibodies against TNF- can protect
old normal (C) (top panel), Alport (A) (middle panel), and murine
against acute renal failure in glycerol-induced animalTGF- type II receptor fused to the Fc region of murine immunoglobu-
lin (Ig)2a (mTGFR:Fc)-treated Alport [A(SR)] (bottom panel) mice models [18]. TNF- added directly to the culture media
were collected onto gelatin-coated film in situ zymography (FIZ) slides can induce apoptosis in cultured proximal tubular epithe-
and subjected to in situ zymography as described in the Methods section.
lial cells [15]. TNF- activates nuclear factor-kappa BInset in bottom panel illustrates that gelatinolytic activity localizes to
the interstitial space. The pro-forms of MMPs are not detected using (NF-B) transcription complex, which, in turn, activates
this method [40]. Bar, 70 m. a variety of genes, including MCP-1, and interleukins
(IL) 1, 4, 6, 8, and 10 [53]. Elevated expression of these
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